NextCell Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022	2021 - 2017
Period Ending	Apr '26 Apr 29, 2026	Dec '25 Dec 31, 2025	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	2021 - 2017
Market Capitalization	129	81	130	93	124	218	Upgrade
Market Cap Growth	37.04%	-37.52%	40.40%	-25.00%	-43.31%	-56.21%	Upgrade
Enterprise Value	103	43	114	72	61	111	Upgrade
Last Close Price	1.16	0.73	1.17	1.27	3.60	6.35	Upgrade
PS Ratio	13.14	8.28	11.78	8.23	8.87	35.05	Upgrade
PB Ratio	2.55	1.61	1.96	1.37	1.63	1.89	Upgrade
P/TBV Ratio	2.55	1.61	1.96	1.37	1.63	1.89	Upgrade
EV/Sales Ratio	10.49	4.34	10.27	6.39	4.34	17.86	Upgrade
Net Debt / Equity Ratio	-0.51	-0.51	-0.58	-0.69	-0.66	-0.84	Upgrade
Net Debt / EBITDA Ratio	0.70	0.70	1.16	1.11	1.23	2.81	Upgrade
Net Debt / FCF Ratio	0.56	0.56	0.90	1.24	1.04	2.37	Upgrade
Asset Turnover	-	-	0.14	0.13	0.13	0.04	Upgrade
Inventory Turnover	-	-	17.24	22.79	14.12	-	Upgrade
Quick Ratio	3.92	3.92	8.05	5.06	5.32	14.40	Upgrade
Current Ratio	5.16	5.16	10.02	6.15	6.67	15.40	Upgrade
Return on Equity (ROE)	-	-	-52.46%	-58.55%	-41.63%	-26.02%	Upgrade
Return on Assets (ROA)	-	-	-28.39%	-31.72%	-24.01%	-15.62%	Upgrade
Return on Capital Employed (ROCE)	-70.60%	-70.60%	-50.30%	-60.50%	-52.10%	-29.80%	Upgrade
Earnings Yield	-30.02%	-47.64%	-26.96%	-45.20%	-32.17%	-15.83%	Upgrade
FCF Yield	-36.04%	-57.20%	-33.03%	-40.79%	-38.72%	-18.74%	Upgrade
Buyback Yield / Dilution	-	-	-87.22%	-18.72%	-	-13.05%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.